Bioartificial Liver System Using Hepatocyte Spheroids
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Liver failure treatment options, such as liver transplantation, are limited by donor organ scarcity, lifelong immunosuppression, and inefficiencies in artificial liver devices due to environmental and nutrient limitations, necessitating an effective artificial liver system.
Innovation Solution
A bioartificial liver system with a bioreactor and cell reservoir containing hepatocyte spheroids, which maintains normal liver metabolism through a selectively permeable barrier and rocking device, enhancing cell longevity and therapy duration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional artificial liver devices are used, then liver failure treatment is provided, but efficiency is limited due to environmental and nutrient limitations
Solution Approach 1:
The system divides the artificial liver into separate functional modules: a bioreactor compartment for hepatocyte cultivation and a plasma treatment compartment. This segmentation allows independent optimization of cell culture conditions and plasma processing, resolving the contradiction between providing liver assistance and maintaining favorable environmental conditions for hepatocyte survival.
Solution Approach 2:
A selective permeability barrier acts as an intermediary between the bioreactor compartment containing hepatocytes and the plasma treatment compartment. This barrier allows beneficial substances to pass while protecting hepatocytes from harmful plasma components, thereby maintaining efficient liver assistance without exposing cells to detrimental environmental factors.
2Duration of action of moving object
If conventional artificial liver devices are used, then liver failure treatment is provided, but therapy duration is limited due to device limitations
Solution Approach 1:
Hepatocytes are pre-cultured and prepared in a controlled bioreactor environment before being introduced to the plasma treatment system. This preliminary action ensures cells are in optimal condition, extending their functional lifespan and thereby increasing therapy duration without compromising device simplicity.
Solution Approach 2:
The selective permeability barrier functions as a flexible membrane that separates the hepatocyte compartment from the plasma compartment. This thin film structure maintains a simple device architecture while providing sophisticated environmental control, allowing extended therapy duration by protecting cells from harmful plasma exposure.
3Reliability
If liver transplantation is performed, then liver failure is treated, but donor organ scarcity limits availability
Solution Approach 1:
The system uses the patient's own blood plasma as the treatment medium, eliminating the need for donor organs. The plasma is collected from the patient and processed through the bioreactor containing hepatocytes, creating a self-sufficient treatment system that addresses liver failure without requiring scarce donor resources.
Solution Approach 2:
Instead of transplanting a physical donor liver, the system creates a functional copy of liver processing capability using hepatocyte spheroids in a bioreactor. These spheroids replicate key liver functions (protein synthesis, metabolism, toxin removal) without requiring actual donor organ tissue, thereby solving the scarcity problem while maintaining treatment effectiveness.
4Reliability
If liver transplantation is performed, then liver failure is treated, but lifelong immunosuppression is required
Solution Approach 1:
The system creates a temporary, non-integrating functional copy of liver processing using external hepatocyte spheroids in a bioreactor. Unlike transplanted organs that require immunosuppression to prevent rejection, these spheroids operate externally and do not integrate with the patient's immune system, thereby eliminating the need for lifelong immunosuppressive therapy while maintaining effective liver function support.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The system improves the efficiency and effectiveness of ex vivo liver assistance by maintaining normal liver metabolism and increasing the potential duration of therapy for patients with liver failure.
Implementation Method 1
a bioreactor that includes a selectively permeable barrier separating a fluid treatment compartment and a cell compartment
Implementation Method 2
a rocking device in contact with the cell reservoir to induce motion in fluid contained in the cell reservoir
Implementation Method 3
allowing the biological fluid to flow through and exit the fluid treatment compartment, thereby treating the biological fluid
Data Source
AI summary
A bioartificial liver system is described that incorporates a cell reservoir and hepatocyte spheroids to both increase the number of and longevity of cells in the system. Additional methods are also described for forming spheroid aggregates from isolated hepatocytes.